title: Interaction between activated VD3 and Ca channel blockers in patients undergoing hemodialysis.
authors.forename: S
authors.initials: S
authors.lastname: Negoro
authors.forename: S
authors.initials: S
authors.lastname: Izumi
authors.forename: T
authors.initials: T
authors.lastname: Furukubo
authors.forename: M
authors.initials: M
authors.lastname: Satoh
authors.forename: C
authors.initials: C
authors.lastname: Matsunaga
authors.forename: T
authors.initials: T
authors.lastname: Yamakawa
authors.forename: S
authors.initials: S
authors.lastname: Ikegawa
authors.forename: H
authors.initials: H
authors.lastname: Nakanishi
authors.forename: D
authors.initials: D
authors.lastname: Kadowaki
authors.forename: S
authors.initials: S
authors.lastname: Hirata
mesh_terms: D017311:Amlodipine / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002117:Calcitriol / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D009543:Nifedipine / Q000627:therapeutic use; D006435:Renal Dialysis
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D006887:Hydroxycholecalciferols; D017311:Amlodipine; D003577:Cytochrome P-450 Enzyme System; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D002117:Calcitriol; D009543:Nifedipine; C008088:alfacalcidol